Financial Performance - The company reported a significant increase in revenue for the first half of 2023, achieving a total of RMB 500 million, representing a growth of 25% year-over-year[1]. - The company's operating revenue for the first half of the year is CNY 110,472,068.86, a decrease of 12.27% compared to the same period last year[21]. - Net profit attributable to shareholders decreased by 28.95% to CNY 39,126,578.03, primarily due to a decline in revenue and an increase in operating costs[22]. - Basic and diluted earnings per share fell by 46.58% to CNY 0.39, influenced by the decrease in net profit and an increase in the number of shares outstanding from 75 million to 100 million[23]. - The company's gross margin for the first half of 2023 was 56.59%, down from 73.15% in the same period of 2022 and 78.29% in 2021[90]. - The net profit after deducting non-recurring gains and losses decreased by 31.99% to CNY 36,012,902.82, reflecting the overall decline in profitability[22]. - The net cash flow from operating activities increased significantly by 643.85% to CNY 15,807,743.92, attributed to improved cash collection and tax refunds received[24]. Market Expansion and Strategy - The company has set a revenue guidance for the second half of 2023, projecting an increase of 20% to reach RMB 600 million[1]. - The company is actively pursuing market expansion, targeting an entry into Southeast Asia by Q4 2023, with an estimated market potential of RMB 200 million[1]. - The company expanded its customer base to over 600 clients, enhancing its brand advantage in market competition[84]. - The company is adapting its testing capabilities to meet the evolving requirements of new electronic components and their failure analysis[42]. Research and Development - Research and development expenses have increased by 10%, totaling RMB 50 million, to support innovation and new technology initiatives[1]. - R&D investment accounted for 10.51% of total revenue, up from 9.2% in the previous year, indicating a 14.24% increase in R&D intensity[73]. - The company has accumulated 253 intellectual property rights, including 16 invention patents and 200 software copyrights[71]. - The company has established a comprehensive research and development system, continuously improving reliability testing technologies and processes[57]. Testing Services and Capabilities - The military electronic component reliability testing service is the largest segment of the company's main business, ensuring the quality and reliability of military equipment[33]. - The company primarily undertakes secondary screening (二筛) for military electronic components, which is crucial for ensuring the reliability of military products[34]. - The company has increased its certified testing projects or parameters to a total of 863, representing a 52.7% increase compared to the same period last year[44]. - The company can conduct reliability testing on various electronic components, including integrated circuits, discrete devices, and MEMS chips[48][49]. Operational Challenges - The company experienced a significant increase in operating costs due to investments in testing equipment and personnel to enhance production capacity and testing capabilities[24]. - The company faces risks related to high accounts receivable, with accounts receivable balance at 264.99 million yuan and notes receivable at 55.25 million yuan[91]. - The company is addressing the risk of declining gross margins due to rising operational costs and increased competition in the military electronic component testing sector[90]. Governance and Compliance - The board of directors has confirmed that all members attended the meeting, ensuring governance compliance[1]. - The report has not been audited, and investors are advised to consider the associated risks[1]. - The company has no plans for share buybacks or dividend distributions in the current fiscal year[1]. - There are no reported instances of non-operational fund occupation by controlling shareholders[1]. Environmental Responsibility - The company has established an environmental protection mechanism and complies with relevant environmental laws and regulations[121]. - The company did not face any administrative penalties related to environmental issues during the reporting period[120]. - The company emphasizes environmental protection as a key component of its sustainable development strategy[122]. Shareholding and Stock Management - The company has committed to shareholding restrictions for major shareholders and executives for a period of 12 to 36 months[126]. - The company will ensure compliance with relevant laws and regulations when formulating share reduction plans post-lock-up[142]. - The company guarantees that the statements and commitments regarding shareholding are true, accurate, complete, and valid, with no concealment or omissions[136]. - The company will not reduce its holdings of pre-IPO shares for 6 months if there are significant legal violations that could lead to delisting[140].

Financial Performance - The company's revenue for Q3 2023 was CNY 46,783,721.43, representing a decrease of 31.75% compared to the same period last year[5]. - The net profit attributable to shareholders for Q3 2023 was CNY 11,411,503.07, down 53.17% year-on-year[5]. - Year-to-date revenue until the end of the reporting period was CNY 157,255,790.29, a decline of 19.14% compared to the previous year[5]. - Year-to-date net profit attributable to shareholders was CNY 50,538,081.10, down 36.38% year-on-year[5]. - The basic and diluted earnings per share for Q3 2023 were both CNY 0.12, a decrease of 50% compared to the same period last year[6]. - The company reported total operating revenue of RMB 157,255,790.29 for the first three quarters of 2023, a decrease of 19.1% compared to RMB 194,475,479.98 in the same period of 2022[28]. - The total profit for the current period is CNY 55,719,258.79, down 39.1% from CNY 91,639,373.24 in the previous period[30]. - The operating profit for the current period is CNY 52,743,733.18, a decline of 42.2% compared to CNY 91,227,235.49 in the previous period[30]. - The total comprehensive income for the current period is CNY 50,208,871.45, down 36.7% from CNY 79,440,019.42 in the previous period[30]. - The basic and diluted earnings per share for the current period are both CNY 0.51, compared to CNY 0.99 in the previous period[30]. Cash Flow and Assets - The net cash flow from operating activities for the year-to-date period was CNY 25,798,914.55, an increase of 70.85% year-on-year[6]. - The net cash flow from operating activities for the first three quarters of 2023 is CNY 25,798,914.55, an increase of 70.9% from CNY 15,099,970.10 in the same period last year[32]. - The cash inflow from investment activities for the current period is CNY 947,686,524.54, with a net cash flow from investment activities of CNY 387,188,180.26, compared to a negative CNY 84,868,270.86 in the previous period[33]. - The cash flow from financing activities for the current period is CNY 18,420,407.24, a significant decrease from CNY 1,222,862,883.56 in the previous period[33]. - The total assets at the end of the reporting period were CNY 1,836,771,854.12, an increase of 6.47% from the end of the previous year[7]. - The total assets of the company reached RMB 1,836,771,854.12 as of September 30, 2023, compared to RMB 1,725,130,329.52 at the end of 2022, reflecting an increase of 6.5%[25]. - The company has significantly increased its cash reserves, with cash and cash equivalents reaching RMB 598,927,609.27 as of September 30, 2023, compared to RMB 167,520,107.22 at the end of 2022, representing a growth of 257.5%[23]. - Inventory levels rose to RMB 11,036,647.27, up 64.5% from RMB 6,705,442.89 at the end of 2022[24]. - Non-current liabilities increased to RMB 47,465,919.34, up from RMB 13,116,060.08 at the end of 2022, indicating a rise of 262.5%[26]. - The company's retained earnings increased to RMB 336,299,974.07, up from RMB 285,761,892.97 at the end of 2022, marking an increase of 17.6%[27]. Shareholder Information - The total number of common shareholders at the end of the reporting period is 3,876[15]. - The largest shareholder, Jian Shui Quan Jun Enterprise Management Center, holds 54,908,065 shares, accounting for 54.91% of total shares[15]. - The top ten shareholders include Ningbo Tongtai Xin Venture Capital, holding 5,400,000 shares (5.40%) and Ningbo Tongyuan Youbo Investment, holding 3,000,000 shares (3.00%)[15]. - The total number of shares involved in margin trading among the top ten shareholders is 120,100 shares[16]. - The company has repurchased a total of 336,871 shares, representing 0.34% of the total share capital, with a total expenditure of RMB 17,197,755.11[18]. - The highest repurchase price per share was RMB 52.87, while the lowest was RMB 49.39[18]. Research and Development - Research and development expenses for Q3 2023 were CNY 5,615,194.83, down 21.19% year-on-year, accounting for 1.97% of revenue[7]. - The company has made substantial investments in R&D, focusing on satellite detection and chip testing, with a strategic partnership established with a satellite research institute[20]. - The company aims to develop a large-scale automated testing model combining artificial intelligence and high-speed computing, addressing significant demand in the satellite industry[20]. - The company has completed the construction of a high-cleanliness testing laboratory of over 400 square meters, enhancing its testing capabilities for satellite products and manned spacecraft components[20]. - The company plans to enhance its testing capabilities, which has led to an increase in operating costs, contributing to the decline in net profit[12]. - The company has added over 7,000 square meters of environmental and electromagnetic compatibility testing facilities, with basic renovations completed[19]. - A wholly-owned subsidiary, Hainan Guoxing Feice Technology Co., Ltd., was established with an investment of RMB 60 million to enhance satellite-related industry capabilities[19]. - The company has completed the business registration procedures for the new subsidiary, Hainan Feice[19]. Market Conditions - The decline in revenue was attributed to a phase adjustment in order demand from the military product market and upstream and downstream customers[12]. - Total operating costs increased to RMB 118,239,629.98 in 2023, up 13.0% from RMB 104,654,418.26 in 2022[28]. - The company aims to strengthen its competitiveness and proximity to aerospace clients through strategic investments[19].

Financial Performance - The company's operating revenue for Q1 2024 was ¥28,670,179.99, representing a decrease of 55.01% compared to the same period last year[5] - The net profit attributable to shareholders was ¥4,571,726.52, down 80.47% year-over-year[5] - The net profit attributable to shareholders after deducting non-recurring gains and losses was ¥3,357,116.13, a decline of 85.60% compared to the previous year[6] - The basic and diluted earnings per share were both ¥0.05, reflecting a decrease of 78.26% year-over-year[6] - Total operating revenue for Q1 2024 was CNY 28,670,179.99, a decrease from CNY 63,719,430.62 in Q1 2023[20] - Operating profit for Q1 2024 was CNY 3,916,860.27, significantly lower than CNY 27,030,104.19 in Q1 2023[21] - Net profit for Q1 2024 was CNY 3,276,392.33, down from CNY 23,413,414.12 in Q1 2023[22] - Earnings per share for Q1 2024 was CNY 0.05, compared to CNY 0.23 in Q1 2023[22] Cash Flow and Liquidity - The net cash flow from operating activities increased significantly by 473.04%, amounting to ¥23,596,244.96[6] - Cash flow from operating activities in Q1 2024 was CNY 61,367,397.49, an increase from CNY 56,850,954.45 in Q1 2023[24] - Net cash flow from operating activities was $23,596,244.96, a significant increase from $4,117,741.59 in the previous period, reflecting improved operational efficiency[25] - The ending cash and cash equivalents balance decreased to $238,364,031.05 from $608,619,985.53, indicating a significant reduction in liquidity[26] - Total cash inflow from operating activities was $63,642,173.32, compared to $57,506,250.09 in the previous period, showing a positive trend in revenue generation[25] Assets and Liabilities - Total assets at the end of the reporting period were ¥1,831,658,112.64, a slight decrease of 0.49% from the end of the previous year[6] - Total current assets decreased from ¥1,337,667,877.21 to ¥1,264,969,335.70, reflecting a decline of about 5.4%[16] - Non-current assets include fixed assets valued at ¥275,072,084.42, down from ¥280,481,531.20, indicating a decrease of approximately 1.5%[16] - Total liabilities were CNY 110,114,812.91, compared to CNY 114,479,442.61 previously[18] - Total equity decreased to CNY 1,721,543,299.73 from CNY 1,726,273,421.26[18] Research and Development - Research and development expenses totaled ¥5,872,639.91, accounting for 20.48% of operating revenue, an increase of 11.34% from the previous year[6] - Research and development expenses for Q1 2024 were CNY 5,872,639.91, slightly up from CNY 5,826,002.54 in Q1 2023[21] Operational Challenges - The decline in revenue and net profit was primarily due to a temporary impact from the downstream military industry, with delayed military orders leading to a decrease in testing order volume[9] - The company made significant investments in equipment and facility leasing to expand testing capabilities, resulting in increased depreciation costs[9] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 5,613[11] - There are no changes in the shareholding structure of the top 10 shareholders due to the transfer of shares in the margin trading business[13] Management and Governance - The company’s chairman, Zhang Ya, is temporarily unable to perform his duties due to being placed under detention, with responsibilities delegated to General Manager Ma Weidong[14] - The company has not disclosed any significant new product developments or market expansion strategies during this reporting period[14] Investment Activities - Total cash inflow from investment activities was $13,900.81, compared to $462,149,334.10 in the prior period, indicating a substantial decrease in investment returns[25] - Cash outflow for capital expenditures was $82,333,578.89, up from $19,228,939.62, highlighting increased investment in fixed assets[25] - The company reported a net cash flow from investment activities of -$82,319,678.08, a decline from $442,920,394.48, suggesting reduced investment activity[25] Tax and Expenses - Cash outflow for employee compensation was $20,900,026.18, down from $28,996,167.96, reflecting cost control measures[25] - Tax payments decreased to $2,231,454.51 from $5,718,700.12, indicating potential tax efficiency improvements[25] Future Outlook - The company plans to implement new accounting standards starting in 2024, which may impact future financial reporting[26]

Financial Performance - The company's operating revenue for Q1 2023 was ¥63,719,430.62, representing a year-on-year increase of 25.70%[5] - The net profit attributable to shareholders was ¥23,413,414.12, reflecting a growth of 24.02% compared to the same period last year[5] - The net profit after deducting non-recurring gains and losses was ¥23,309,582.57, which is an increase of 30.28% year-on-year[5] - Total operating revenue for Q1 2023 reached ¥63,719,430.62, a 25.7% increase from ¥50,693,382.15 in Q1 2022[17] - Net profit for Q1 2023 was ¥23,413,414.12, representing a 24.0% increase compared to ¥18,878,213.63 in Q1 2022[18] - Operating profit for Q1 2023 was ¥27,030,104.19, an increase of 27.8% from ¥21,134,546.97 in Q1 2022[18] - The basic and diluted earnings per share for Q1 2023 were both ¥0.23, down from ¥0.25 in Q1 2022[19] Cash Flow and Assets - The net cash flow from operating activities was ¥4,117,741.59, with no applicable year-on-year comparison[5] - Cash flow from operating activities generated a net amount of ¥4,117,741.59 in Q1 2023, recovering from a negative cash flow of ¥4,861,162.89 in Q1 2022[19] - Cash flow from investing activities showed a net inflow of ¥442,920,394.48 in Q1 2023, compared to a net outflow of ¥14,427,794.05 in Q1 2022[20] - As of March 31, 2023, the company's cash and cash equivalents increased to ¥605,957,100.29 from ¥167,520,107.22 as of December 31, 2022, representing a growth of approximately 262%[13] - The company ended Q1 2023 with cash and cash equivalents of ¥608,619,985.53, significantly up from ¥28,647,239.46 at the end of Q1 2022[20] Assets and Liabilities - The total assets at the end of the reporting period were ¥1,736,650,969.19, showing a slight increase of 0.67% from the end of the previous year[6] - The company's total assets reached ¥1,736,650,969.19, a marginal increase from ¥1,725,130,329.52, reflecting a growth of about 0.66%[14] - Total liabilities decreased to ¥51,449,784.06 from ¥63,342,558.51, a reduction of approximately 19%[15] - The company's equity attributable to shareholders increased to ¥1,685,201,185.13 from ¥1,661,787,771.01, showing a growth of about 1.4%[15] Research and Development - The company's R&D investment totaled ¥5,826,002.54, accounting for 9.14% of operating revenue, a decrease of 1.85 percentage points from the previous year[6] - Research and development expenses for Q1 2023 were ¥5,826,002.54, slightly up from ¥5,568,944.96 in Q1 2022[17] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 4,510[8] - There are no significant changes in the shareholder structure or related party transactions reported during the period[11] Future Outlook - The company is focusing on expanding its market presence and developing new technologies, although specific details were not provided in the content[12] - The company has plans for future product launches and market expansion strategies, but further specifics were not detailed in the provided content[12]

一、主要会计数据和财务指标 | 报告期指标 | 2024年年报 | 2023年年报 | 本年比上年增减(%) | 2022年年报 | | --- | --- | --- | --- | --- | | 基本每股收益（元） | -0.2100 | 0.4800 | -143.75 | 1.1400 | | 每股净资产（元） | 16.08 | 16.81 | -4.34 | 16.68 | | 每股公积金(元) | 12.66 | 12.66 | 0 | 12.66 | | 每股未分配利润(元) | 2.80 | 3.33 | -15.92 | 2.91 | | 每股经营现金流(元) | - | - | - | - | | 营业收入(亿元) | 1.44 | 2.01 | -28.36 | 2.43 | | 净利润(亿元) | -0.21 | 0.48 | -143.75 | 0.97 | | 净资产收益率(%) | -1.28 | 2.56 | -150 | 10.97 | 数据四舍五入，查看更多财务数据>> 不分配不转增 | 名称 | 持有数量(万股) | 占总股本比例(%) | 增减情况(万股) | | ...

证券代码：688053 证券简称：思科瑞 公告编号：2025-012 成都思科瑞微电子股份有限公司关于变更持续督导保荐代表人的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内 容的真实性、准确性和完整性依法承担法律责任。 成都思科瑞微电子股份有限公司（以下简称"公司"）近日收到中国银河证券股份有限公司（以下简 称"银河证券"）出具的《中国银河证券股份有限公司关于更换成都思科瑞微电子股份有限公司首次公开 发行股票项目持续督导保荐代表人的函》。现将有关情况公告如下： 银河证券作为公司首次公开发行股票项目的保荐机构，原指定陈召军先生、姚召五先生担任持续督导保 荐代表人。银河证券保荐代表人陈召军先生因工作变动，不再担任公司首次公开发行股票项目持续督导 保荐代表人。为保证持续督导工作的有序进行，银河证券另行委派李强先生接替陈召军先生担任公司持 续督导保荐代表人继续履行持续督导工作。 本次变更后，银河证券指派的担任公司首次公开发行股票项目持续督导的保荐代表人为姚召五先生和李 强先生。 2025年4月19日 李强先生简历 李强先生，中国银河证券股份有限公司投资银行总部保荐代表 ...

证券代码：688053 证券简称：思科瑞 公告编号：2025-012 成都思科瑞微电子股份有限公司 关于变更持续督导保荐代表人的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 本次变更后，银河证券指派的担任公司首次公开发行股票项目持续督导的保 荐代表人为姚召五先生和李强先生。 本次保荐代表人变更不会影响银河证券对公司的持续督导工作，亦不会对公 司的生产经营活动产生不利影响。公司董事会对陈召军先生担任公司保荐代表人 期间所做出的贡献表示衷心感谢！ 李强先生的简历详见附件。 特此公告。 成都思科瑞微电子股份有限公司（以下简称"公司"）近日收到中国银河证券 股份有限公司（以下简称"银河证券"）出具的《中国银河证券股份有限公司关于 更换成都思科瑞微电子股份有限公司首次公开发行股票项目持续督导保荐代表 人的函》。现将有关情况公告如下： 银河证券作为公司首次公开发行股票项目的保荐机构，原指定陈召军先生、 姚召五先生担任持续督导保荐代表人。银河证券保荐代表人陈召军先生因工作变 动，不再担任公司首次公开发行股票项目持续督导保荐代表人 ...

思科瑞跌2.21% 2022年上市募13.88亿中国银河保荐 中国经济网北京3月26日讯 思科瑞(688053.SH)今日收报27.42元，跌幅2.21%。目前该股处于破发状 态。 思科瑞于2022年7月8日在上交所科创板上市，公开发行的股票数量为2500.00万股，发行价格为 55.53元/股，保荐人（主承销商）为中国银河证券股份有限公司，保荐代表人为陈召军、姚召五。 思科瑞首次公开发行股票募集资金总额为138,825.00万元，募集资金净额为125,250.66万元。思科瑞 最终募集资金净额较原计划多63,394.25万元。思科瑞于2022年7月5日披露的招股说明书显示，该公司拟 募集资金61,856.41万元，分别用于成都检测试验基地建设项目、环境试验中心建设项目、无锡检测试验 基地建设项目、研发中心建设项目、补充流动资金。 思科瑞首次公开发行股票的发行费用总额为13,574.34万元（发行费用均为不含税金额），其中，中 国银河证券股份有限公司获得承销及保荐费用10,760.38万元。 2024年度业绩快报公告显示，2024年公司实现营业总收入14,314.13万元，较上年同期下降 26.60%；归属于 ...

证券代码：688053 证券简称：思科瑞 公告编号：2025-011 成都思科瑞微电子股份有限公司 股东减持股份结果公告 本公司董事会、全体董事及相关股东保证本公告内容不存在任何虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律 责任。 重要内容提示： 大股东持有的基本情况 本次减持计划实施前，成都思科瑞微电子股份有限公司（以下简称"公司" 或"思科瑞"）股东宁波通泰信创业投资合伙企业(有限合伙) (以下简称"宁波 通泰信")持有公司股份 5,020,000 股,占公司总股本 5.02%；其一致行动人宁波 通元优博创业投资合伙企业(有限合伙) (以下简称"宁波通元优博")持有公司 股份 2,460,000 股，占公司总股本 2.46%。股东宁波通泰信及其一致行动人宁波 通元优博合计持有思科瑞 7,480,000 股，占公司总股本的 7.48%。上述股份均为 公司首次公开发行前取得的股份，已于 2023 年 7 月 10 日解除限售并上市流通。 减持计划的实施结果情况 公司于 2024 年 12 月 2 日在上海证券交易所（www.sse.com.cn）披露了《成 都思科瑞微电子 ...

思科瑞首次公开发行股票的发行费用总额为13,574.34万元（发行费用均为不含税金额），其中，中国银 河证券股份有限公司获得承销及保荐费用10,760.38万元。 中国经济网北京3月19日讯 思科瑞(688053.SH)今日收报29.60元，跌幅3.90%。 目前该股处于破发状态。 思科瑞于2022年7月8日在上交所科创板上市，公开发行的股票数量为2500.00万股，发行价格为55.53元/ 股，保荐人（主承销商）为中国银河证券股份有限公司，保荐代表人为陈召军、姚召五。 思科瑞首次公开发行股票募集资金总额为138,825.00万元，募集资金净额为125,250.66万元。 思科瑞最终募集资金净额较原计划多63,394.25万元。 思科瑞于2022年7月5日披露的招股说明书显示，该公司拟募集资金61,856.41万元，分别用于成都检测试 验基地建设项目、环境试验中心建设项目、无锡检测试验基地建设项目、研发中心建设项目、补充流动 资金。 ...